
CoreValve Evolut-R TAVR (29mm) via Percutaneous Femoral Access
Week of June 14th 2016
Case and Plan:
34-year-old obese male multiple CAD risk factors presented with NSTEMI. A Cardiac Cath on July 26, 2021 revealed 3 V CAD: 100% mid LAD (J-CTO Score 2) with 80% D1 bifurcation, 90% LCx OM1, 90% distal RCA with SYNTAX Score of 28. Patient underwent successful intervention of distal RCA using Promus DES and LCx OM1 using Promus DES. Patient is now planned for staged PCI of LAD CTO and diagonal bifurcation using Mini-Crush technique as part of complete revascularization.